Corridor Pharmaceuticals

Corridor Pharmaceuticals

Small molecule arginase inhibitors for cancer treatment.

HQ location
Towson, United States
Launch date
Employees
Enterprise value
$52—78m
Recent deals
Authorizing premium user...